Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Completed · Phase 1

Conditions studied: Advanced Cancer, Advanced Malignancies

In brief

This is a phase 1, open-label, multicenter, ascending-dose escalation study of cemiplimab, alone and in combination with other anti-cancer therapies in patients with advanced malignancies.

Key facts

Study ID

NCT02383212

Run by

Regeneron Pharmaceuticals

People needed

398

Starts

2015-02-02

Expected to finish

2019-11-18

Last updated by the study team

2020-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Banner MD Anderson Cancer Center — Gilbert, Arizona, United States
• Western Regional Medical Center — Goodyear, Arizona, United States
• Mayo Clinic — Phoenix, Arizona, United States
• University of Arizona Cancer Center — Tucson, Arizona, United States
• City of Hope National Medical Center — Duarte, California, United States
• The Angeles Clinic and Research Institute — Los Angeles, California, United States
• Ronald Reagan UCLA Medical Center — Los Angeles, California, United States
• Stanford University — Stanford, California, United States
• Sarah Cannon Research Institute at HealthONE — Denver, Colorado, United States
• Norwalk Hospital — Norwalk, Connecticut, United States
• Georgetown University Medical Center — Washington D.C., District of Columbia, United States
• H Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Winship Cancer Institute, Emory University — Atlanta, Georgia, United States
• University of Chicago — Chicago, Illinois, United States
• Indiana University — Indianapolis, Indiana, United States
• University of Kansas Cancer Center — Fairway, Kansas, United States
• Dana Farber Cancer Institute — Boston, Massachusetts, United States
• Barbara Ann Karmanos Cancer Center — Detroit, Michigan, United States
• Washington University School of Medicine Siteman Cancer Center — St Louis, Missouri, United States
• Nebraska Methodist Hospital — Omaha, Nebraska, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
• Columbia University Medical Center — New York, New York, United States
• Laura & Isaac Perlmutter Cancer Center — New York, New York, United States
• Mount Sinai Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.